OPKO Health subsidiary ModeX Therapeutics has started dosing patients with its tetraspecific T-cell engager, MDX2003, for ...

Patients dosed in Phase 1 safety and tolerability study of MDX2003, a novel T-cell engager designed to optimize killing of lymphomas Preclinical studies presented at 2025 American Society of ...

Episode 240 of The Robot Report Podcast features a recap of the MODEX 2026 trade show with Eugene Demaitre, editorial ...

The show's unique combination of hands-on product and technology demonstrations, education and face-to-face connections makes Modex the can't-miss experience for supply chain professionals this year.

Dr. Elias Zerhouni, ModeX Chairman, former President of Global R&D at Sanofi and former NIH Director, named President and Vice Chairman of OPKO Dr. Gary Nabel, ModeX President and CEO, former Chief ...

Flux Power Holdings, Inc . (NASDAQ: FLUX), a leading developer of advanced lithium-ion energy storage solutions and software for material handling and industrial applications, today announced it has ...

Intuitive Handling – The Destuff-it 2.0 introduces a joystick drive control and Human-Machine Interface (HMI). Learning to ...

MHI recognizes Locus Array as a breakthrough innovation pushing the boundaries of what is possible in material handling ...

ModeX Therapeutics initiates clinical trial of tetraspecific antibody for treatment of B-cell lymphomas: Weston, Massachusetts Friday, April 24, 2026, 16:00 Hrs [IST] ModeX Therap ...